newsfilter
← Latest News
Business Wire·

CaryHealth Launches Direct-to-Patient Program for Cipher Pharmaceuticals' Natroba™ (spinosad)

CPHRFTSX:CPH
  • CaryHealth launched a direct-to-patient platform in partnership with Cipher Pharmaceuticals to streamline access to Natroba (spinosad) for head lice and scabies.
  • The new model replaces fragmented virtual-care workflows with a unified experience that integrates prescribing, clinical engagement, and pharmacy fulfillment.
  • Patients can access telehealth for prescriptions, receive same-day delivery in CaryRx geographies, and track order status via the CaryConnect portal.
  • The platform eliminates common barriers such as multiple logins and separate payment steps to optimize the patient journey.
  • Natroba holds the FDA's "Complete Cure" designation for scabies and is the only FDA-approved prescription head lice treatment proven superior to Nix in phase III trials.
  • Bryan Jacobs of Cipher Pharmaceuticals emphasized the solution's ability to provide fast local pick-up or delivery options for families.
  • Areo Nazari, CEO of CaryHealth, stated the initiative aims to return families to normal life immediately upon seeking care.